Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 01 Jul 2021

Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment

in Drugs Outcomes Research and Policies

Luis Sarabia De Ardanaz
Jose M. Andreu-Ubero
Miriam Navidad-Fuentes
Miguel Ángel Ferrer-González
Victor Ruíz del Valle
Inmaculada Salcedo-Bellido
Rocío Barrios-Rodríguez
Rafael Cáliz-Cáliz
Pilar Requena

Frontiers in Pharmacology

doi 10.3389/fphar.2021.620187

3,594 views
12 citations

Original Research

Published on 01 Jul 2021

Evaluation of a Pharmacist-Led Remote Warfarin Management Model Using a Smartphone Application (Yixing) in Improving Patients’ Knowledge and Outcomes of Anticoagulation Therapy

in Drugs Outcomes Research and Policies

Shudan Jiang
Qiuyi He
Jiajia Yan
Liyan Zhao
Yifan Zheng
Pan Chen
Xiao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.677943

4,143 views
14 citations

Original Research

Published on 29 Jun 2021

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis

in Drugs Outcomes Research and Policies

Ahmed A. Abulfathi
Veronique de Jager
Elana van Brakel
Helmuth Reuter
Nikhil Gupte
Naadira Vanker
Grace L. Barnes
Eric Nuermberger
Susan E. Dorman
Andreas H. Diacon

Frontiers in Pharmacology

doi 10.3389/fphar.2021.637618

3,968 views
4 citations

Original Research

Published on 29 Jun 2021

Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in Medicare

in Drugs Outcomes Research and Policies

Z. Kevin Lu
Xiaomo Xiong
Jacob Brown
Ashley Horras
Jing Yuan
Minghui Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.706289

5,281 views
17 citations

Original Research

Published on 29 Jun 2021

Analysis of Suspension of Clinical Trials for Drug Registration in China

in Drugs Outcomes Research and Policies

Xian Su
Xiaocong Pang
Xin Zeng
Yi Gao
Yimin Cui
Haixue Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.598574

4,059 views

Original Research

Published on 25 Jun 2021

Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure

in Drugs Outcomes Research and Policies

Sabine Vogler
Peter Schneider
Martin Zuba
Reinhard Busse
Dimitra Panteli

Frontiers in Pharmacology

doi 10.3389/fphar.2021.625296

21,221 views
51 citations

Systematic Review

Published on 25 Jun 2021

The Use of Oseltamivir as Adjunctive Therapy for the Treatment of Hand-Food-and-Mouth Disease: A Meta-Analysis of Randomized Clinical Trials

in Drugs Outcomes Research and Policies

Yijing Zhao
Yangyang Sun
Raphael N. Alolga
Gaoxiang Ma
Fan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.653691

8,737 views
1 citation

Original Research

Published on 24 Jun 2021

Patient and Payer Preferences for Additional Value Criteria

in Drugs Outcomes Research and Policies

Ivett Jakab
Melanie D. Whittington
Elizabeth Franklin
Susan Raiola
Jonathan D. Campbell
Zoltán Kaló
R. Brett McQueen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.690021

4,593 views
10 citations

Opinion

Published on 24 Jun 2021

Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19

in Drugs Outcomes Research and Policies

Charu Sharma
Niraj Kumar Jha
M. F. Nagoor Meeran
Chandragouda R. Patil
Sameer N. Goyal
Shreesh Ojha

Frontiers in Pharmacology

doi 10.3389/fphar.2021.603997

101,104 views
23 citations

Perspective

Published on 23 Jun 2021

The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives

in Drugs Outcomes Research and Policies

Valeria Belleudi
Filomena Fortinguerra
Francesca R. Poggi
Serena Perna
Renata Bortolus
Serena Donati
Antonio Clavenna
Anna Locatelli
Marina Davoli
Antonio Addis

Frontiers in Pharmacology

doi 10.3389/fphar.2021.699062

2,606 views
10 citations

Original Research

Published on 22 Jun 2021

Machine Learning Approaches to Predict Risks of Diabetic Complications and Poor Glycemic Control in Nonadherent Type 2 Diabetes

in Drugs Outcomes Research and Policies

Yuting Fan
Enwu Long
Lulu Cai
Qiyuan Cao
Xingwei Wu
Rongsheng Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.665951

7,506 views
28 citations

Original Research

Published on 17 Jun 2021

Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe

in Drugs Outcomes Research and Policies

Jane Robertson
Vera Vlahović-Palčevski
Kotoji Iwamoto
Liselotte Diaz Högberg
Brian Godman
Dominique L. Monnet
Sarah Garner
Klaus Weist
ESAC-Net Study Group
WHO Europe AMC Network Study Group

Frontiers in Pharmacology

doi 10.3389/fphar.2021.639207

12,699 views
37 citations

Original Research

Published on 17 Jun 2021

Choosing Optimal Antibiotics for the Treatment of Patients Infected With Enterobacteriaceae: A Network Meta-analysis and Cost-Effectiveness Analysis

in Drugs Outcomes Research and Policies

Ruiying Han
Mengmeng Teng
Ying Zhang
Tao Zhang
Taotao Wang
Jiaojiao Chen
Sihan Li
Bo Yang
Yaling Shi
Yalin Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.656790

6,764 views
3 citations

Original Research

Published on 14 Jun 2021

Development and Validation of a Nomogram for Predicting Drug-Induced Acute Kidney Injury in Hospitalized Patients: A Case-Control Study Based on Propensity-Score Matching

in Drugs Outcomes Research and Policies

Chengxuan Yu
Daihong Guo
Chong Yao
Yu Zhu
Siyuan Liu
Xianghao Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.657853

3,332 views
9 citations

Original Research

Published on 10 Jun 2021

Exploring the Appropriate Price of Semaglutide for Type 2 Diabetes Patients Based on Cost-Utility Analysis in China

in Drugs Outcomes Research and Policies

Shanshan Hu
Xiaorong Su
Xun Deng
Yong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.701446

7,960 views
6 citations

Original Research

Published on 08 Jun 2021

High Prevalence of Multimorbidity and Polypharmacy in Elderly Patients With Chronic Pain Receiving Home Care are Associated With Multiple Medication-Related Problems

in Drugs Outcomes Research and Policies

Juliana Schneider
Engi Abd Elhady Algharably
Andrea Budnick
Arlett Wenzel
Dagmar Dräger
Reinhold Kreutz

Frontiers in Pharmacology

doi 10.3389/fphar.2021.686990

9,858 views
46 citations

Navigation group

Articles

Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment

Evaluation of a Pharmacist-Led Remote Warfarin Management Model Using a Smartphone Application (Yixing) in Improving Patients’ Knowledge and Outcomes of Anticoagulation Therapy

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis

Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in Medicare

Analysis of Suspension of Clinical Trials for Drug Registration in China

Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure

The Use of Oseltamivir as Adjunctive Therapy for the Treatment of Hand-Food-and-Mouth Disease: A Meta-Analysis of Randomized Clinical Trials

Patient and Payer Preferences for Additional Value Criteria

Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19

The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives

Machine Learning Approaches to Predict Risks of Diabetic Complications and Poor Glycemic Control in Nonadherent Type 2 Diabetes

Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe

Choosing Optimal Antibiotics for the Treatment of Patients Infected With Enterobacteriaceae: A Network Meta-analysis and Cost-Effectiveness Analysis

Development and Validation of a Nomogram for Predicting Drug-Induced Acute Kidney Injury in Hospitalized Patients: A Case-Control Study Based on Propensity-Score Matching

Exploring the Appropriate Price of Semaglutide for Type 2 Diabetes Patients Based on Cost-Utility Analysis in China

High Prevalence of Multimorbidity and Polypharmacy in Elderly Patients With Chronic Pain Receiving Home Care are Associated With Multiple Medication-Related Problems